As a specialized Contract Research Organization (CRO), Creative Biolabs understands that the future of medicine lies within the intricate ecosystems of the human body. The gut microbiome, often referred to as our "second genome," has emerged as a cornerstone of human health, influencing everything from metabolic homeostasis and immune regulation to neurological signaling via the gut-brain axis. As the field shifts from purely observational studies to functional interventions, the demand for precision-engineered microbial solutions has never been higher.
Our Genetic Engineering for Gut Microbiome Engineering service is designed to bridge the gap between synthetic biology and clinical application. We provide a comprehensive suite of tools to transform commensal bacteria into intelligent, programmable "living factories" capable of sensing, responding to, and treating disease from within.
Our genetic engineering service offers a robust platform for the modification of diverse microbial species found within the human gastrointestinal tract. By utilizing advanced genome editing technologies, we empower researchers to go beyond traditional probiotics. We help you design and create Live Biotherapeutic Products (LBPs) that can deliver therapeutic payloads, such as anti-inflammatory cytokines, short-chain fatty acids (SCFAs), or enzymatic inhibitors, directly to the site of interest.
The core of our mission is precision. Whether you are looking to knock out a specific metabolic pathway that contributes to toxicity or knock in a synthetic gene circuit to act as a diagnostic biosensor, our team of molecular biologists and microbiologists provides the technical expertise to turn your hypothesis into a validated lead candidate.
Success starts with the right chassis. We work with a wide range of strains, including:
We utilize state-of-the-art tools to ensure high-efficiency modifications:
We build "smart" bacteria that only work when and where they are needed:
To support our engineering services, we provide a catalog of standardized products designed to streamline your preclinical research:
Working with a CRO that understands both the biology and the engineering is critical. Our platform offers several key advantages:
Our genome-integrated modifications are more stable than plasmid-based systems, ensuring the therapeutic effect lasts throughout the colonization period.
We prioritize marker-free and biocontainment strategies from day one, facilitating a smoother transition to IND-enabling studies.
Our facility is equipped with specialized anaerobic chambers and fermentation systems, allowing us to engineer the "dark matter" of the microbiome that many other labs cannot handle.
We don't just engineer the strain; we validate it. Our platform includes transcriptomics, metabolomics, and in vivo colonization assays to prove efficacy.
The versatility of engineered gut microbes allows for applications across a broad spectrum of therapeutic areas:
For decades, researchers relied on fecal microbiota transplants (FMT) or natural probiotics to modulate gut health. While effective, these methods lack precision and consistency. The rise of Synthetic Biology has changed the landscape.
The potential of the gut microbiome to serve as a platform for next-generation medicine is immense. By combining your innovative ideas with our robust genetic engineering infrastructure, we can create precision therapies that truly change patient lives. Whether you are a biotech startup or an established pharmaceutical company, we are here to provide the technical backbone for your microbiome-based drug development journey.
Yes. We have specialized anaerobic facilities and have developed proprietary transformation protocols for various "hard-to-transform" anaerobes, including members of the Bacteroidetes and Firmicutes phyla.
We employ several strategies, including chromosomal integration (which is much less likely to transfer than plasmids) and the use of "non-mobilizable" genetic elements. We can also design strains with metabolic dependencies that prevent them from surviving outside the lab or a specific host environment.
Absolutely. As a full-service CRO, we offer germ-free and humanized mouse models to evaluate colonization, stability, and therapeutic efficacy of your engineered leads.
Timelines vary based on the complexity of the modification and the growth rate of the host strain, but a typical project from design to validated clone takes approximately 12 to 24 weeks.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.